In particular, it has been demonstrated that cancer-associated fibroblasts (CAFs) promote the mesenchymal phenotypes of tumor cells via the TGF-β pathway11,12, implying that the composition of the stromal component alone could be clinically meaningful for classifying consensus molecular subtype (CMS) 4 in CRC. This evidence concerns the gene TGFB1 and cancer.